Safety and efficacy of single-needle leukocyte apheresis for treatment of ulcerative colitis.
leukocyte apheresis
single needle
ulcerative colitis
Journal
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ISSN: 1744-9987
Titre abrégé: Ther Apher Dial
Pays: Australia
ID NLM: 101181252
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
12
6
2020
medline:
15
9
2021
entrez:
12
6
2020
Statut:
ppublish
Résumé
Leukocyte apheresis (LCAP) is a safe and effective treatment for active ulcerative colitis (UC) in Japan. Nevertheless, a limitation of LCAP is its requirement for two puncture sites (double-needle [DN] apheresis), sometimes leading to problems with needle puncture. Single-needle (SN) apheresis is useful in hemodialysis and reduces needle puncture pain. If SN apheresis were found to be useful in LCAP for UC, it may reduce patient burden. The aim of this study was to compare the safety and efficacy of SN apheresis with that of DN apheresis. Twenty-four patients with active UC were retrospectively enrolled. They underwent either SN apheresis (n = 12) or conventional double-needle (DN) apheresis (n = 12) at the Kurume University Hospital from February 2014 to March 2018. At each session, we recorded access problems defined by the time required to initiate apheresis and the frequency of puncture-related problems, as well as blood circuit clotting, defined as clotting necessitating interruption of apheresis and changing of the circuit. Efficacy was assessed using partial Mayo scores. The number of apheresis sessions was comparable between SN and DN apheresis (9.0 ± 2.0 times vs 9.6 ± 1.4 times, mean ± SEM). SN significantly reduced the time required to start apheresis (10.0 ± 5.4 minutes vs 19.4 ± 11.9 minutes, P < .05) as well as needle puncture troubles (0.9% vs 11.5%, P < .05). SN had comparable frequency of blood clotting episodes (5.6% vs 8.7%). SN apheresis had similar clinical efficacy (P < .001 in SN and P < .01 in DN). The improvement and remission rates were comparable between groups. SN apheresis may be safe and effective and may reduce patient burden during UC treatment. Nevertheless, further comparative studies are needed.
Identifiants
pubmed: 32526089
doi: 10.1111/1744-9987.13539
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
503-510Informations de copyright
© 2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
Références
Sawada K, Kusugami K, Suzuki Y, et al. Leukocytapheresis in ulcerative colitis: Results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol. 2005;100(6):1362-1369.
Hibi T, Sakuraba A. Is there a role for apheresis in gastrointestinal disorders? Nat Clin Pract Gastroenterol Hepatol. 2005;2(5):200-201.
Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther. 2006;6(5):453-466.
Mitsuyama K, Yamasaki H, Kuwaki K, Takedatsu H, Sata M. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease. Curr Pharm Des. 2009;15(18):2110-2119.
Yamasaki H, Mitsuyama K, Masuda J, et al. Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis. Dig Dis Sci. 2010;55(3):596-606.
Fujihara C, Ogawa T, Ono J, Seiichi M. Measurement and analysis of flow and pressure in tubes during single-needle dialysis. Nihon Biorheology Gakkai-Zasshi. 2012;26(1):5-7.
Imai T, Yamasaki H, Mitsuyama K, et al. Single Needle Granulocyte and Monocyte Apheresis for Ulcerative Colitis: A Retrospective Safety Analysis. Kurume Med J. 2020;66(1):1-7. http://dx.doi.org/10.2739/kurumemedj.ms661002.
Shimazu K, Fukuchi T, Kim I, et al. Efficacy and usefulness of new single-needle intensive granulocyte and monocyte adsorptive apheresis in active ulcerative colitis patients without corticosteroids and biologics. Ther Apher Dial. 2016;20(4):383-389.
Shibata H, Kuriyama T, Yamawaki N. Cellsorba. Ther Apher Dial. 2003;7(1):44-47.
Dzik S. Leukodepletion blood filters: Filter design and mechanisms of leukocyte removal. Transfus Med Rev. 1993;7(2):65-77.
Yokoyama Y, Matsuoka K, Kobayashi T, et al. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: Treatment outcomes of 847 patients in clinical practice. J Crohns Colitis. 2014;8(9):981-991.
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625-1629.
Gubensek J, Buturovic-Ponikvar J, Ponikvar R. Regional citrate anticoagulation for single-needle hemodialysis: A prospective clinical study. Blood Purif. 2007;25(5-6):454-456.
Huang SH, Shah S, Thomson BK, Laporte S, Filler G, Lindsay RM. What is single needle cannulation hemodialysis: Is it adequate? Blood Purif. 2014;38(1):13-17.
McLeod BC, McKenna R, Viernes A, et al. Plateletpheresis with the COBE spectra single needle access option. J Clin Apher. 1991;6(1):24-27.
Kopp KF, Gutch CF, Kolff WJ. Single needle dialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):75-81.
Vanholder R, De Paepe M, Hoenich NA, Ringoir S. Double lumen needle in unipuncture dialysis type double headpump. Int J Artif Organs. 1981;4(2):72-74.
De Clippele M, Vanholder R, De Roose J, Derom F, Ringoir S. Fistula survival in single needle hemodialysis. Int J Artif Organs. 1983;6(2):71-73.
Rostoker G, Griuncelli M, Loridon C, Bourlet T, Welsch K, Benmaadi A. Improving the efficiency of short-term single-needle hemodialysis. Ren Fail. 2009;31(4):261-266.
Wagner SJ, Seetharaman S, Fau - Kurtz J, Kurtz J. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer. Transfusion. 2012;52(11):2427-2431.
Nagayama K, Takedatsu H, Mitsuyama K, et al. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients. Ther Apher Dial. 2014;18(3):244-251.